Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Asian Currencies Slide as Iran Tensions Boost Dollar and Oil Prices 
Indian Stock Market Drops as Iran Conflict Fuels Oil Price and Inflation Fears 
Trump Rejects Iran Proposal as Strait of Hormuz Crisis Pushes Oil Prices Higher 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern 
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
China Inflation Jumps as Iran Conflict Drives Energy Costs Higher 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.
